Phase-Change Nanoparticles Using Highly Volatile Perfluorocarbons: Toward a Platform for Extravascular Ultrasound Imaging

Recent efforts using perfluorocarbon (PFC) nanoparticles in conjunction with acoustic droplet vaporization has introduced the possibility of expanding the diagnostic and therapeutic capability of ultrasound contrast agents to beyond the vascular space. Our laboratories have developed phase-change nanoparticles (PCNs) from the highly volatile PFCs decafluorobutane (DFB, bp =-2 °C) and octafluoropropane (OFP, bp =-37 °C ) for acoustic droplet vaporization. Studies with commonly used clinical ultrasound scanners have demonstrated the ability to vaporize PCN emulsions with frequencies and mechanical indices that may significantly decrease tissue bioeffects. In addition, these contrast agents can be formulated to be stable at physiological temperatures and the perfluorocarbons can be mixed to modulate the balance between sensitivity to ultrasound and general stability. We herein discuss our recent efforts to develop finely-tuned diagnostic/molecular imaging agents for tissue interrogation. We discuss studies currently under investigation as well as potential diagnostic and therapeutic paradigms that may emerge as a result of formulating PCNs with low boiling point PFCs.

[1]  Y. Kawai,et al.  Real‐time imaging of the lymphatic channels and sentinel lymph nodes of the stomach using contrast‐enhanced ultrasonography with Sonazoid in a porcine model , 2011, Cancer science.

[2]  N. Shaheen Advances in Barrett's esophagus and esophageal adenocarcinoma. , 2005, Gastroenterology.

[3]  T. Porter,et al.  Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms. , 1995, Circulation.

[4]  O. Kamp,et al.  Coronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubbles in acute ST segment elevation myocardial infarction. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[5]  D. Christensen,et al.  Microbubble Generation in Phase-Shift Nanoemulsions used as Anticancer Drug Carriers. , 2009, Bubble science engineering and technology.

[6]  Alexander L. Klibanov,et al.  Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications , 2006, Investigative radiology.

[7]  B. Goldberg,et al.  Contrast‐Enhanced Sonographic Imaging of Lymphatic Channels and Sentinel Lymph Nodes , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[8]  Samuel A Wickline,et al.  Targeted ultrasonic contrast agents for molecular imaging and therapy. , 2001, Current problems in cardiology.

[9]  Jameel A Feshitan,et al.  Microbubble size isolation by differential centrifugation. , 2009, Journal of colloid and interface science.

[10]  S. Caruthers,et al.  Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions , 2010, Angiogenesis.

[11]  B. Goldberg,et al.  Contrast‐Enhanced Ultrasound Imaging of Sentinel Lymph Nodes After Peritumoral Administration of Sonazoid in a Melanoma Tumor Animal Model , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[12]  R. M. Thomas,et al.  Ultrasound contrast agents nucleate inertial cavitation in vitro. , 1995, Ultrasound in medicine & biology.

[13]  H. Feußner,et al.  International Workshop on the clinical impact of endoscopic ultrasound in gastroenterology. , 2000, Endoscopy.

[14]  P. Roberson,et al.  Persistent Penumbra in a Rabbit Stroke Model: Incidence and Histologic Characteristics , 2011, Stroke research and treatment.

[15]  Paul A Dayton,et al.  Tailoring the Size Distribution of Ultrasound Contrast Agents: Possible Method for Improving Sensitivity in Molecular Imaging , 2007, Molecular imaging.

[16]  J. Tokar,et al.  Endoscopic Ultrasound Drainage of Pancreatic Pseudocyst: A Prospective Comparison with Conventional Endoscopic Drainage , 2006, Endoscopy.

[17]  C. Lundgren,et al.  The theory and application of intravascular microbubbles as an ultra-effective means of transporting oxygen and other gases. , 2004, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[18]  J. Willmann,et al.  Molecular body imaging: MR imaging, CT, and US. part I. principles. , 2012, Radiology.

[19]  S. Umemura,et al.  Nanoparticles with Multiple Perfluorocarbons for Controllable Ultrasonically Induced Phase Shifting , 2005 .

[20]  Thomas D. Wang,et al.  Molecular imaging in gastrointestinal endoscopy. , 2010, Gastroenterology.

[21]  Nathan A. Baker,et al.  Interaction of melittin peptides with perfluorocarbon nanoemulsion particles. , 2011, The journal of physical chemistry. B.

[22]  Nikita Reznik,et al.  Investigation of vaporized submicron perfluorocarbon droplets as an ultrasound contrast agent. , 2011, Ultrasound in medicine & biology.

[23]  A. Olszowka,et al.  Tissue nitrogen elimination in oxygen-breathing pigs is enhanced by fluorocarbon-derived intravascular micro-bubbles. , 2005, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

[24]  Nikita Reznik,et al.  Optical studies of vaporization and stability of fluorescently labelled perfluorocarbon droplets , 2012, Physics in medicine and biology.

[25]  P. Carson,et al.  Initial investigation of acoustic droplet vaporization for occlusion in canine kidney. , 2010, Ultrasound in medicine & biology.

[26]  R. Campbell,et al.  Tumor physiology and delivery of nanopharmaceuticals. , 2006, Anti-cancer agents in medicinal chemistry.

[27]  J. Willmann,et al.  Molecular body imaging: MR imaging, CT, and US. Part II. Applications. , 2012, Radiology.

[28]  P. Carson,et al.  Acoustic droplet vaporization for temporal and spatial control of tissue occlusion: a kidney study , 2005, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[29]  Vladimir P Torchilin,et al.  Passive and active drug targeting: drug delivery to tumors as an example. , 2010, Handbook of experimental pharmacology.

[30]  Christine A Iacobuzio-Donahue,et al.  Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. , 2004, American journal of clinical pathology.

[31]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[32]  K. Tachibana,et al.  Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. , 1995, Circulation.

[33]  J B Fowlkes,et al.  Acoustic droplet vaporization for therapeutic and diagnostic applications. , 2000, Ultrasound in medicine & biology.

[34]  Prateek Sharma,et al.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus. , 2011, Gastroenterology.

[35]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Zhuo,et al.  Targeted delivery in breast cancer cells via iodine: nuclear localization sequence conjugate. , 2011, Bioconjugate chemistry.

[37]  Katherine W Ferrara,et al.  Contrast-enhanced US of microcirculation of superficially implanted tumors in rats. , 2003, Radiology.

[38]  Oliver D Kripfgans,et al.  Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion. , 2010, Ultrasound in medicine & biology.

[39]  Chih-Kuang Yeh,et al.  Intracellular acoustic droplet vaporization in a single peritoneal macrophage for drug delivery applications. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[40]  D. Crossman,et al.  Microbubble-enhanced ultrasound for vascular gene delivery , 2000, Gene Therapy.

[41]  R. Zhuo,et al.  Construction of cell penetrating peptide vectors with N-terminal stearylated nuclear localization signal for targeted delivery of DNA into the cell nuclei. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Ultrasonic analysis of peptide- And antibody-targeted microbubble contrast agents for molecular imaging of α vβ 3-expressing cells , 2004 .

[43]  Janusz Jankowski,et al.  A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. , 2004, Gastroenterology.

[44]  Paul A Dayton,et al.  Microfluidic generation of acoustically active nanodroplets. , 2012, Small.

[45]  C. Lundgren,et al.  Intravascular Fluorocarbon-stabilized Microbubbles Protect Against Fatal Anemia in Rats , 2006, Artificial cells, blood substitutes, and immobilization biotechnology.

[46]  R Gramiak,et al.  Echocardiography of the aortic root. , 1968, Investigative radiology.

[47]  N. Shaheen,et al.  The role of radiofrequency ablation in the management of Barrett's esophagus. , 2011, Gastrointestinal endoscopy clinics of North America.

[48]  J. Wang-Rodriguez,et al.  Hard shell gas-filled contrast enhancement particles for colour Doppler ultrasound imaging of tumors. , 2010, MedChemComm.

[49]  Kullervo Hynynen,et al.  Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. , 2003, Ultrasound in medicine & biology.

[50]  Thomas D. Wang,et al.  Affinity peptide for targeted detection of dysplasia in Barrett's esophagus. , 2010, Gastroenterology.

[51]  P. Vilmann,et al.  Endoscopic ultrasound-guided fine-needle aspiration biopsy in esophageal cancer. , 2005, Endoscopy.

[52]  Paul A Dayton,et al.  Phase-change contrast agents for imaging and therapy. , 2012, Current pharmaceutical design.

[53]  Paul S. Sheeran,et al.  Ultrasound molecular imaging with customizable nanoscale phase-change contrast agents: An in-vitro feasibility study , 2012, 2012 IEEE International Ultrasonics Symposium.

[54]  J. Shea,et al.  Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[55]  A. Kabalnov Ostwald Ripening and Related Phenomena , 2001 .

[56]  J. Gorce,et al.  Influence of Bubble Size Distribution on the Echogenicity of Ultrasound Contrast Agents: A Study of SonoVue™ , 2000, Investigative radiology.

[57]  Paul A Dayton,et al.  Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[58]  Zhanwen Xing,et al.  The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging , 2010, Nanotechnology.

[59]  G. Caletti,et al.  The rediscovery of endoscopic ultrasound (EUS) in gastric cancer staging , 2012, Endoscopy.

[60]  Paul A. Dayton,et al.  Ultrasound‐mediated therapies using oil and perfluorocarbon‐filled nanodroplets , 2006 .

[61]  A. Alexandrov,et al.  A Pilot Randomized Clinical Safety Study of Sonothrombolysis Augmentation With Ultrasound-Activated Perflutren-Lipid Microspheres for Acute Ischemic Stroke , 2008, Stroke.

[62]  R. Mattrey,et al.  Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging. , 1989, AJR. American journal of roentgenology.

[63]  Andrea Prosperetti,et al.  Bubble phenomena in sound fields: part one , 1984 .

[64]  Paul S. Sheeran,et al.  Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons. , 2012, Biomaterials.

[65]  Jeffrey E. Lee,et al.  Impact of Resection Status on Pattern of Failure and Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma , 2007, Annals of surgery.

[66]  Paul A Dayton,et al.  Advances in Molecular Imaging with Ultrasound , 2010, Molecular imaging.

[67]  Paul S. Sheeran,et al.  Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging. , 2011, Ultrasound in medicine & biology.

[68]  Paul S. Sheeran,et al.  Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle. , 2013, Ultrasound in medicine & biology.

[69]  M. Washington,et al.  Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. , 2002, The Journal of clinical investigation.

[70]  Alexander L. Klibanov,et al.  Microbubbles in ultrasound-triggered drug and gene delivery. , 2008, Advanced drug delivery reviews.

[71]  L. Lyon,et al.  Microgel translocation through pores under confinement. , 2010, Angewandte Chemie.

[72]  J. Fléjou,et al.  High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins , 2002, Virchows Archiv.

[73]  Yun Zhou,et al.  Controlled permeation of cell membrane by single bubble acoustic cavitation. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[74]  N. Rapoport,et al.  Application of ultrasound for targeted nanotherapy of malignant tumors , 2009, Acoustical physics.

[75]  Paul A Dayton,et al.  Improving Sensitivity in Ultrasound Molecular Imaging by Tailoring Contrast Agent Size Distribution: In Vivo Studies , 2010, Molecular imaging.

[76]  E. Wisner,et al.  Sentinel Node Detection Using Contrast-Enhanced Power Doppler Ultrasound Lymphography , 2003, Investigative radiology.

[77]  D. Carney,et al.  Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results. , 1993, AJR. American journal of roentgenology.

[78]  T. Porter,et al.  An in vitro study of a phase-shift nanoemulsion: a potential nucleation agent for bubble-enhanced HIFU tumor ablation. , 2010, Ultrasound in medicine & biology.